D. Goodall

Molecular Assessment of C4d-Positive Renal Transplant Biopsies Without Evidence of Rejection

C. Roufosse, P. Brookes, Hannah Beckwith, 2018, Kidney international reports.

Prevalence of frailty and cognitive impairment in older transplant candidates - a preview to the Kidney Transplantation in Older People (KTOP): impact of frailty on outcomes study

N. Thomas, E. Brown, L. Johansson, 2022, BMC Nephrology.

Risk factors and outcomes of delayed graft function in renal transplant recipients receiving a steroid sparing immunosuppression protocol

V. Papalois, M. Willicombe, A. Mclean, 2017, World journal of transplantation.

Kidney Transplantation With Minimized Maintenance: Alemtuzumab Induction With Tacrolimus Monotherapy—An Open Label, Randomized Trial

C. Roufosse, N. Duncan, A. Warrens, 2011, Transplantation.

Alemtuzumab dose adjusted for body weight is associated with earlier lymphocyte repletion and less infective episodes in the first year post renal transplantation – a retrospective study

M. Willicombe, A. Mclean, D. Taube, 2017, Transplant international : official journal of the European Society for Organ Transplantation.

High Intrapatient Variability of Tacrolimus Levels and Outpatient Clinic Nonattendance Are Associated With Inferior Outcomes in Renal Transplant Patients

M. Willicombe, A. Mclean, D. Taube, 2017, Transplantation direct.

Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era

J. Crane, P. Hill, G. Lucisano, 2020, Kidney International Reports.

Incidence, risk factors, and outcomes of stroke post‐transplantation in patients receiving a steroid sparing immunosuppression protocol

M. Willicombe, A. Mclean, D. Taube, 2015, Clinical transplantation.

Alemtuzumab induction therapy in HIV-positive renal transplant recipients.

F. Post, Rachael Jones, S. Kinloch, 2017, AIDS.

Lack of seroresponse to SARS-CoV-2 booster vaccines given early post-transplant in patients primed pre-transplantation

P. Kelleher, L. Lightstone, M. Prendecki, 2023, Frontiers in Immunology.